PuSH - Publication Server of Helmholtz Zentrum München

Koczian, F.* ; Nagło, O.* ; Vomacka, J.* ; Vick, B. ; Servatius, P.* ; Zisis, T.* ; Hettich, B.* ; Kazmaier, U.* ; Sieber, S.A.* ; Jeremias, I. ; Zahler, S.* ; Braig, S.*

Targeting the endoplasmic reticulummitochondria interface sensitizes leukemia cells to cytostatics.

Haematologica 104, 546-555 (2019)
Publ. Version/Full Text Postprint DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Combination chemotherapy has proven to be a favorable strategy to treat acute leukemia. However, the introduction of novel compounds remains challenging and is hindered by a lack of understanding of their mechanistic interactions with established drugs. In the present study, we demonstrate a highly increased response of various acute leukemia cell lines, drug-resistant cells and patient-derived xenograft cells by combining the recently introduced protein disulfide isomerase inhibitor PS89 with cytostatics. In leukemic cells, a pro-teomics-based target fishing approach revealed that PS89 affects a whole network of endoplasmic reticulum homeostasis proteins. We elucidate that the strong induction of apoptosis in combination with cytostatics is orchestrated by the PS89 target B-cell receptor-associated protein 31, which transduces apoptosis signals at the endoplasmic reticulum-mitochondria interface. Activation of caspase-8 and cleavage of B-cell receptor-associated protein 31 stimulate a pro-apoptotic crosstalk including release of calcium from the endoplasmic reticulum and an increase in the levels of reactive oxygen species resulting in amplification of mitochondrial apoptosis. The findings of this study promote PS89 as a novel chemosensitizing agent for the treatment of acute leukemia and uncovers that targeting the endoplasmic reticulum-mitochondrial network of cell death is a promising approach in combination therapy.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.570
1.585
8
8
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Acute Myeloid Leukemia ; Adult Acute Lymphoblastic Leukemia ; Molecular Pharmacology ; Pediatric Acute Lymphoblastic Leukemia; Protein Disulfide-isomerase; Induced Apoptosis; Resistance; Network; Inhibitor; Mechanisms; Reveals; Redox
Language english
Publication Year 2019
Prepublished in Year 2018
HGF-reported in Year 2018
ISSN (print) / ISBN 0390-6078
e-ISSN 1592-8721
Quellenangaben Volume: 104, Issue: 3, Pages: 546-555 Article Number: , Supplement: ,
Publisher Ferrata Storti Foundation
Publishing Place Via Giuseppe Belli 4, 27100 Pavia, Italy
Reviewing status Peer reviewed
Institute(s) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
POF-Topic(s) 30204 - Cell Programming and Repair
Research field(s) Stem Cell and Neuroscience
PSP Element(s) G-506600-001
Scopus ID 85063878548
PubMed ID 30309851
Erfassungsdatum 2018-10-22